Dominik (born 1991) is a former medical student, who following his passion for drug design and development obtained Bachelor's and Master's degrees, both in Chemistry, at the University of Warsaw (in 2016 and 2018, respectively). He specialised in organic chemistry and throughout the years of education gained interdisciplinary experience at the interface of chemistry and biology, both in the academia and the industry.

Dominik joined Caflisch group in November 2018, where his main focus remains on understanding complex regulatory networks of m6A epitranscriptomics, associated RNA biology and its relation to human health and disease.

His free time Dominik dedicates to music, travelling, running and practising yoga.